Immune response to mycobacterium tuberculosis and identification of molecular markers of disease

American Journal of Respiratory Cell and Molecular Biology

Volumn 40, Issue 4, 2009, Pages 398-409

  Gonzalez Juarrero, Mercedes ^a   Kingry, Luke C ^a,b   Ordway, Diane J ^a   Henao Tamayo, Marcela ^a   Harton, Marisa ^a   Basaraba, Randall J ^a   Hanneman, William H ^c   Orme, Ian M ^a   Slayden, Richard A ^a,b,c  

^a Department of Microbiology Immunology and Pathology   (United States)

^b Rocky Mountain Regional Center of Excellence   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Immunity; Transcriptional response; Tuberculosis

Indexed keywords

CHEMOKINE; COMPLEMENT RECEPTOR; CYTOKINE; FC RECEPTOR; INTERFERON; MOLECULAR MARKER; PROTEIN; BIOLOGICAL MARKER; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DISEASE COURSE; DISEASE MARKER; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC CODE; GENETIC TRANSCRIPTION; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INFLAMMATORY INFILTRATE; LUNG GRANULOMATOSIS; LUNG TUBERCULOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROARRAY ANALYSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; T LYMPHOCYTE ACTIVATION; UNINDEXED SEQUENCE; ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TUBERCULOSIS;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; LUNG; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSCRIPTION, GENETIC; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63349090338     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0248OC     Document Type: Article

References (68)

1. Lefford MJ. Transfer of adoptive immunity to tuberculosis in mice. Infect Immun 1975;11:1174-1181.
2. Orme IM, Collins FM. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy: requirement for T cell-deficient recipients. J Exp Med 1983;158:74-83.
3. Orme IM. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol 1987;138:293-298.
4. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993;178:2243-2247.
5. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-2254.
6. Irwin SM, Izzo AA, Dow SW, Skeiky YA, Reed SG, Alderson MR, Orme IM. Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the mtb72f polyprotein. Infect Immun 2005; 73:5809-5816.
7. Serbina NV, Flynn JL. Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect Immun 1999;67:3980-3988.
8. Shi S, Blumenthal A, Hickey CM, Gandotra S, Levy D, Ehrt S. Expression of many immunologically important genes in Mycobacte-rium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-{alpha}{beta} receptor and stat1. J Immunol 2005;175:3318-3328.
9. Jang S, Uematsu S, Akira S, Salgame P. IL-6 and IL-10 induction from dendritic cells in response to Mycobacterium tuberculosis is predominantly dependent on TLR2-mediated recognition. J Immunol 2004;173: 3392-3397.
10. kanazawa N, Tashiro K, Inaba K, Miyachi Y. Dendritic cell immunoactivating receptor, a novel C-type lectin immunoreceptor, acts as an activating receptor through association with fc receptor {gamma} chain. J Biol Chem 2003;278:32645-32652.
11. Rachman H, Strong M, Ulrichs T, Grode L, Schuchhardt J, Mollenkopf H, Kosmiadi GA, Eisenberg D, Kaufmann SH. Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis. Infect Immun 2006;74:1233-1242.
12. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf H, Ziegler A, Kaufmann S. Candidate biomarkers for discrimination between infection and disease caused by mycobacte-rium tuberculosis. J Mol Med 2007;85:613-621.
13. Rosseau S, Hocke A, Mollenkopf H, Schmeck B, Suttorp N, Kaufmann SH, Zerrahn J. Comparative transcriptional profiling of the lung reveals shared and distinct features of Streptococcus pneumoniae and influenza a virus infection. Immunology 2007;120:380-391.
14. Mollenkopf HJ, Hahnke K, Kaufmann SH. Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis. Microbes Infect 2006; 8:136-144.
15. Available from: geospiza, Seattle, WA at: http://www.genesifter.net/web/.
16. Raychaudhuri S, Stuart JM, Altman RB. Principal components analysis to summarize microarray experiments: Application to sporulation time series. Pac Symp Biocomput 2000;455-466.
17. Yeung KY, Ruzzo WL. Principal component analysis for clustering gene expression data. Bioinformatics 2001;17:763-774.
18. Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs DM, Ghilardi N, deSauvage F, Cooper AM. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 2005;175:788- 795.
19. Gonzalez-Juarrero M, Hattle JM, Izzo A, Junqueira-Kipnis AP, Shim TS, Trapnell BC, Cooper AM, Orme IM. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J Leukoc Biol 2005;77:914-922.
20. Rhoades ER, Frank AA, Orme IM. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacte-rium tuberculosis. Tuber Lung Dis 1997;78:57-66.
21. Kincaid EZ, Wolf AJ, Desvignes L, Mahapatra S, Crick DC, Brennan PJ, Pavelka MS Jr, Ernst JD. Codominance of TLR2-dependent and TLR-independent modulation of MHC class II in Mycobacterium tuberculosis infection in vivo. J Immunol 2007;179:3187-3195.
22. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macro-phages. Proc Natl Acad Sci USA 1999;96:14459-14463.
23. Pompei L, Jang S, Zamlynny B, Ravikumar S, McBride A, Hickman SP, Salgame P. Disparity in IL-12 release in dendritic cells and macro-phages in response to Mycobacterium tuberculosis is due to use of distinct tlrs. J Immunol 2007;178:5192-5199.
24. Schierloh P, Yokobori N, Aleman M, Landoni V, Geffner L, Musella RM, Castagnino J, Baldini M, Abbate E, de la Barrera SS, et al. Mycobacterium tuberculosis-induced gamma interferon production by natural killer cells requires cross talk with antigen-presenting cells involving toll-like receptors 2 and 4 and the mannose receptor in tuberculous pleurisy. Infect Immun 2007;75:5325-5337.
25. Schlesinger LS, Kaufman TM, Iyer S, Hull SR, Marchiando LK. Differences in mannose receptor-mediated uptake of lipoarabino-mannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. J Immunol 1996;157:4568-4575.
26. Rothfuchs AG, Bafica A, Feng CG, Egen JG, Williams DL, Brown GD, Sher A. Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. J Immunol 2007;179:3463-3471.
27. Hickman SP, Chan J, Salgame P. Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization. J Immunol 2002; 168:4636-4642.
28. Ehrt S, Schnappinger D, Bekiranov S, Drenkow J, Shi S, Gingeras TR, Gaasterland T, Schoolnik G, Nathan C. Reprogramming of the macrophage transcriptome in response to interferon-gamma and My-cobacterium tuberculosis: Signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med 2001;194:1123-1140.
29. MacMicking JD, Taylor GA, McKinney JD. Immune control of tuberculosis by IFN-{gamma}-inducible lrg-47. Science 2003;302:654-659.
30. Cooper AM, Pearl JE, Brooks JV, Ehlers S, Orme IM. Expression of the nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect Immun 2000; 68:6879-6882.
31. Ehlers S, Kutsch S, Benini J, Cooper A, Hahn C, Gerdes J, Orme I, Martin C, Rietschel ET. Nos2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads. Immunology 1999;98:313-323.
32. Johann AM, Barra V, Kuhn AM, Weigert A, von Knethen A, Brune B. Apoptotic cells induce arginase II in macrophages, thereby attenuating no production. FASEB J 2007;21:2704-2712.
33. Popov A, Schultze JL. IDO-expressing regulatory dendritic cells in cancer and chronic infection. J Mol Med 2008;86:145-160.
34. Fenhalls G, Stevens L, Moses L, Bezuidenhout J, Betts JC. Helden Pv, Lukey PT, Duncan K. In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions. Infect Immun 2002;70:6330-6338.
35. Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, Eum SY, Taylor K, Klein E, Manjunatha U, Gonzales J, et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 2008;76:2333-2340.
36. Vergne I, Fratti RA, Hill PJ, Chua J, Belisle J, Deretic V. Mycobacterium tuberculosis phagosome maturation arrest: Mycobacterial phos-phatidylinositol analog phosphatidylinositol mannoside stimulates early endosomal fusion. Mol Biol Cell 2004;15:751-760.
37. Sun J, Deghmane AE, Soualhine H, Hong T, Bucci C, Solodkin A, Hmama Z. Mycobacterium bovis BCG disrupts the interaction of rab7 with rilp contributing to inhibition of phagosome maturation. J Leukoc Biol 2007;82:1437-1445.
38. Cooper AM, D'Souza C, Frank AA, Orme IM. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect Immun 1997;65:1317-1320.
39. Zhao T, Zhang H, Guo Y, Fan Z. Granzyme k directly processes bid to release cytochrome c and endonuclease g leading to mitochondria-dependent cell death. J Biol Chem 2007;282:12104-12111.
40. Bade B, Lohrmann J, ten Brinke A, Wolbink AM, Wolbink GJ, ten Berge IJ, Virchow JC Jr, Luttmann W, Hack CE. Detection of soluble human granzyme k in vitro and in vivo. Eur J Immunol 2005;35:2940- 2948.
41. Wojciechowski W, DeSanctis J, Skamene E, Radzioch D. Attenuation of MHC class II expression in macrophages infected with Myco-bacterium bovis bacillus calmette-geurin involves class II trans-activator and depends on the nramp1 gene. J Immunol 1999;163: 2688-2696.
42. Pai RK, Convery M, Hamilton TA, Boom WH, Harding CV. Inhibition of IFN-{gamma}-induced class II transactivator expression by a 19-kda lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion. J Immunol 2003;171:175-184.
43. Pennini ME, Pai RK, Schultz DC, Boom WH, Harding CV. Mycobacterium tuberculosis 19-kda lipoprotein inhibits IFN-{gamma}-induced chromatin remodeling of MHC2ta by TLR2 and MAPK signaling. J Immunol 2006;176:4323-4330.
44. Pflugh DL, Maher SE, Bothwell AL. Ly-6i, a new member of the murine ly-6 superfamily with a distinct pattern of expression. J Immunol 2000; 165:313-321.
45. Coma G, Pena R, Blanco J, Rosell A, Borras FE, Este JA, Clotet B, Ruiz L, Parkhouse RM, Bofill M. Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10. Clin Exp Immunol 2006;145:535-544.
46. Okuda J, Arikawa Y, Takeuchi Y, Mahmoud MM, Suzaki E, Kataoka K, Suzuki T, Okinaka Y, Nakai T. Intracellular replication of Edward-siella tarda in murine macrophage is dependent on the type III secretion system and induces an up-regulation of anti-apoptotic NF-[kappa]B target genes protecting the macrophage from staurosporine-induced apoptosis. Microb Pathog 2006;41:226-240.
47. Teixeira AL Jr, Cardoso F, Souza AL, Teixeira MM. Increased serum concentrations of monokine induced by interferon-gamma/CXCL9 and interferon-gamma-inducible protein 10/CXCL-10 in Sydenham's chorea patients. J Neuroimmunol 2004;150:157-162.
48. Proost P, Verpoest S, Van de Borne K, Schutyser E, Struyf S, Put W, Ronsse I, Grillet B, Opdenakker G, Van Damme J. Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids. J Leukoc Biol 2004; 75:777-784.
49. Fulkerson PC, Zimmermann N, Brandt EB, Muntel EE, Doepker MP, Kavanaugh JL, Mishra A, Witte DP, Zhang H, Farber JM, et al. Negative regulation of eosinophil recruitment to the lung by the chemokine monokine induced by IFN-gamma (MIG, CXCL9). Proc Natl Acad Sci USA 2004;101:1987-1992.
50. Alessandri AL, Souza AL, Oliveira SC, Macedo GC, Teixeira MM, Teixeira AL. Concentrations of CXCL8, CXCL9 and STNFR1 in plasma of patients with pulmonary tuberculosis undergoing treatment. Inflamm Res 2006;55:528-533.
51. Valbuena G, Bradford W, Walker DH. Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group. Am J Pathol 2003;163:1357-1369.
52. Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma- inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjogren's syndrome. Arthritis Rheum 2002;46:2730- 2741.
53. Yoneyama H, Narumi S, Zhang Y, Murai M, Baggiolini M, Lanzavecchia A, Ichida T, Asakura H, Matsushima K. Pivotal role of dendritic cell-derived cxcl10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J Exp Med 2002;195:1257-1266.
54. Stiles LN, Hosking MP, Edwards RA, Strieter RM, Lane TE. Differential roles for cxcr3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS. Eur J Immunol 2006;36:613-622.
55. Quandt J, Dorovini-Zis K. The beta chemokines ccl4 and ccl5 enhance adhesion of specific CD4+ T cell subsets to human brain endothelial cells. J Neuropathol Exp Neurol 2004;63:350-362.
56. Ubogu EE, Callahan MK, Tucky BH, Ransohoff RM. Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier: implications for therapeutically modulating neuroinflamma-tion. J Neuroimmunol 2006;179:132-144.
57. Fahy OL, Townley SL, McColl SR. Cxcl16 regulates cell-mediated immunity to Salmonella enterica serovar enteritidis via promotion of gamma interferon production. Infect Immun 2006;74:6885-6894.
58. Morgan AJ, Guillen C, Symon FA, Huynh TT, Berry MA, Entwisle JJ, Briskin M, Pavord ID, Wardlaw AJ. Expression of cxcr6 and its ligand cxcl16 in the lung in health and disease. Clin Exp Allergy 2005; 35:1572-1580.
59. Thorn CF, Lu ZY, Whitehead AS. Regulation of the human acute phase serum amyloid a genes by tumour necrosis factor-α, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines. Scand J Immunol 2004;59:152-158.
60. Gettins PG. Keeping the serpin machine running smoothly. Genome Res 2000;10:1833-1835.
61. Zhang H, Meng F, Chu CL, Takai T, Lowell CA. The src family kinases hck and fgr negatively regulate neutrophil and dendritic cell chemo-kine signaling via PIR-b. Immunity 2005;22:235-246.
62. Pereira S, Zhang H, Takai T, Lowell CA. The inhibitory receptor PIR- b negatively regulates neutrophil and macrophage integrin signaling. J Immunol 2004;173:5757-5765.
63. Yamazaki T, Nagumo H, Hayashi T, Sugane K, Agematsu K. CD72- mediated suppression of human naive B cell differentiation by down-regulating x-box binding protein 1. Eur J Immunol 2005;35:2325-2334.
64. Parnes JR, Pan C. CD72, a negative regulator of B-cell responsiveness. Immunol Rev 2000;176:75-85.
65. Reignat S, Webster GJ, Brown D, Ogg GS, King A, Seneviratne SL, Dusheiko G, Williams R, Maini MK, Bertoletti A. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 2002;195:1089-1101.
66. Doherty PC. Immune exhaustion: Driving virus-specific CD8+ T cells to death. Trends Microbiol 1993;1:207-209.
67. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol 2001;19:595-621.
68. Gonzalez-Juarrero M, Turner OC, Turner J, Marietta P, Brooks JV, Orme IM. Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis. Infect Immun 2001;69:1722-1728.